Unassociated Document



 


 

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549

 

Form SD
 

SPECIALIZED DISCLOSURE REPORT



 

 

 
Perseon Corporation
 
(Exact Name of Registrant as Specified in Charter)
 

     
 
 
Delaware
 
 
001-32526
 
 
75-1590407
 
  (State or Other Jurisdiction of Incorporation)
 
(Commission File No.)
 
(I.R.S. Employer Identification Number)
     
2188 West 2200 South, Salt Lake City, Utah     84119 
(Address of Principal Executive Offices)
  (Zip Code) 
     
Scott Mayfield     801-972-5555 
(Name and telephone number, including area code, of the person to contact in connection with this report.)
 
 
                                                                            
 


 
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:


 

       Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2014.     ý

 



 
 

 
 
Section 1          Conflict Minerals Disclosure
 
 
Item 1.01 Conflict Minerals Disclosure and Report, Exhibit
 
 
Conflict Minerals Disclosure
 
 
A copy of  Perseon (formerly BSD Medical)  Corporation’s Conflict Minerals Report is filed as Exhibit 1.01 hereto and is publicly available at www.perseonmedical.com.
 
 
Item 1.02 Exhibit
 
 
Perseon has filed, as an exhibit to this Form SD, the Conflict Minerals Report required by Item 1.01.
 
 
Section 2          Exhibit
 
 
Item 2.01 Exhibits
 
 
The following exhibit is filed as part of this report:
 
 
Exhibit 1.01 — Conflict Minerals Report as required by Item 1.01 and 1.02 of this Form.
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.


Perseon Corporation
Date:  May 29, 2015

By:    /s/ William S. Barth                       
Name:           William S. Barth
Title:           Chief Financial Officer